Business
ALPEK/A: 2026 guidance targets $450–$500M EBITDA, with deleveraging and asset sales prioritized
ALPEK/A: 2026 guidance targets $450–$500M EBITDA, with deleveraging and asset sales prioritized

About this update from Alpek, S.a.b. De C.v. Class A
2025 saw a 30% drop in EBITDA due to overcapacity and weak demand, but free cash flow improved 57%. 2026 guidance projects $450–$500 million EBITDA, with deleveraging and asset sales as top priorities. Market recovery remains uncertain, but strategic growth and cost controls are in focus.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
View stock analysis, news, and events for Alpek, S.a.b. De C.v. Class A